Department of Gastroenterology and Internal Medicine, University Hospital Brno, Faculty of Medicine, Masaryk University, Jihlavska 20, 62500, Brno, Czech Republic.
Department of Surgery, University Hospital Brno, Faculty of Medicine, Masaryk University, Jihlavska 20, 62500, Brno, Czech Republic.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2022 May;166(2):228-235. doi: 10.5507/bp.2021.040. Epub 2021 Jul 2.
Acromegaly is a disorder associated with hypersecretion of growth hormone, most usually caused by a pituitary adenoma. Dysmotility of the gastrointestinal tract has been reported in acromegalic patients. Achalasia is a disorder characterized by aperistalsis of the oesophagus with incomplete lower oesophageal sphincter relaxation and whose aetiology remains unknown. Mutations in some genes have previously been associated with the development of acromegaly or achalasia. The study aims were to analyse mutations in selected genes in a woman having both of these diseases, to identify their aetiological factors, and to suggest explanations for the co-incidence of acromegaly and achalasia.
A female patient with acromegaly, achalasia, and a multinodular thyroid gland with hyperplastic colloid nodules underwent successful treatment of achalasia via laparoscopic Heller myotomy, a thyroidectomy was performed, and the pituitary macroadenoma was surgically excised via transnasal endoscopic extirpation. Germline DNA from the leukocytes was analysed by sequencing methods for a panel of genes. No pathogenic mutation in AAAS, AIP, MEN1, CDKN1B, PRKAR1A, SDHB, GPR101, and GNAS genes was found in germline DNA. The somatic mutation c.601C>T/p.R201C in the GNAS gene was identified in DNA extracted from a tissue sample of the pituitary macroadenoma.
We here describe the first case report to our knowledge of a patient with both acromegaly and achalasia. Association of acromegaly and soft muscle tissue hypertrophy may contribute to achalasia's development. If one of these diagnoses is determined, the other also should be considered along with increased risk of oesophageal and colorectal malignancy.
肢端肥大症是一种与生长激素过度分泌相关的疾病,最常见的病因是垂体腺瘤。已有研究报道肢端肥大症患者存在胃肠道动力障碍。贲门失弛缓症是一种以食管蠕动缺失伴不完全下食管括约肌松弛为特征的疾病,其病因尚不清楚。先前已有研究报道一些基因的突变与肢端肥大症或贲门失弛缓症的发生有关。本研究旨在分析同时患有这两种疾病的女性患者中选定基因的突变情况,以确定其病因,并对肢端肥大症和贲门失弛缓症同时发生的原因提出解释。
一位女性患者同时患有肢端肥大症、贲门失弛缓症和伴有增生性胶体结节的多结节甲状腺肿,成功接受了腹腔镜下 Heller 肌切开术治疗贲门失弛缓症,行甲状腺切除术,经鼻内镜经蝶窦切除术切除垂体大腺瘤。通过测序方法对白细胞的种系 DNA 进行了一组基因的分析。在种系 DNA 中未发现 AAAS、AIP、MEN1、CDKN1B、PRKAR1A、SDHB、GPR101 和 GNAS 基因的致病性突变。在从垂体大腺瘤组织样本中提取的 DNA 中发现了 GNAS 基因的 c.601C>T/p.R201C 体细胞突变。
我们在此描述了首例已知的同时患有肢端肥大症和贲门失弛缓症的患者病例。肢端肥大症和软组织结构肥大的相关性可能有助于贲门失弛缓症的发生。如果确定了其中一种诊断,也应该考虑另一种诊断,并注意增加食管和结直肠恶性肿瘤的风险。